Clinical-biological Score for Upper Gastrointestinal Bleeding

NCT05688501 | Completed

• 1 other identifier: GIB-ED
• Study Type: observational
• Target: 150
• Locations: 1 country
• Sites: 1

Brief Summary

Gastrointestinal bleeding is a frequent reason for consultation in the Emergency Department. It is a real emergency associated with fairly significant morbidity and mortality. The incidence of upper gastrointestinal bleeding (HDH) has been reported to be 67-103 per 100,000 adults per year in the UK with mortality rates of 2%-8%. While Lower Gastrointestinal Bleeding (LBHB) has a lower incidence estimated at 33 per 100,000 adults per year. Additionally, compared to HDB, HDB appears to have less need for hemostatic intervention and lower mortality.

Conditions

Gastro Intestinal Bleeding

Outcome Measures

Primary Outcomes (4)

• re-bleeding

  Hemorrhagic recurrence is defined by recurrence of hematemesis, melena or rectal bleeding after discharge from hospital within 30 days

  30 days

• re-hospitalization

  re- hospitalisation for Hemorrhagic recurrence is defined by recurrence of hematemesis, melena or rectal bleeding after discharge from hospital within 30 days

  30 days

• All cause mortality

  The primary outcome was all-cause in-hospital mortality rate

  30 days

• comparaison with the glasgow blatchford score

  comparaison with the glasgow blatchford score

  30 days

Interventions

descriptiv group OTHER

no intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Upper gastrointestinal bleeding (HDH) was defined as a presentation with hematemesis, blackish vomiting and/or melena. Lower gastrointestinal hemorrhage (LBH) was defined as a presentation with red blood or blood clots or blood mixed with stool on clinical examination.

You may qualify if:

• Patients over the age of 18 consulting the emergency department of Sahloul Hospital in Sousse for exteriorized upper and/or lower digestive haemorrhage, of non-traumatic cause;

You may not qualify if:

• patient under the age of 18
• diagnosis of external hemorrhoids / perianal lesions
• Not consenting
• The lost sight

Sponsors & Collaborators

• Hôpital Universitaire Sahloul: lead

Study Sites (1)

HU Sahloul, sousse, Tunisia

Sousse, Itinéraire Ceinture Cité Sahloul, 4054, Tunisia

Location

MeSH Terms

Conditions

Gastrointestinal Hemorrhage

Condition Hierarchy (Ancestors)

Gastrointestinal Diseases; Digestive System Diseases; Hemorrhage; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Riadh Boukef, professor

  CHU Sahloul, Emergency department, sousse

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: November 29, 2022
• First Posted: January 18, 2023
• Study Start: September 1, 2019
• Primary Completion: September 1, 2022
• Study Completion: September 1, 2022
• Last Updated: January 26, 2023

Record last verified: 2023-01

Locations

TU (1)